Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Sales | 0 | 6 | 1,188 | 19,689 | 0 |
| Gross Profit | N/A | 6 | 1,188 | 19,689 | N/A |
| Operating Expenses | 0 | 10,136 | 9,061 | 9,373 | 0 |
| Operating Income | N/A | -10,130 | -7,873 | 10,316 | N/A |
| Other Income | 0 | 272 | -1,510 | 2,551 | 0 |
| Pre-tax Income | 0 | -9,858 | -9,383 | 12,867 | 0 |
| Income Tax | N/A | N/A | N/A | 50 | N/A |
| Net Income Continuous | N/A | -9,858 | -9,383 | 12,817 | N/A |
| Net Income | $N/A | $-9,858 | $-9,383 | $12,817 | $N/A |
| EPS Basic Total Ops | N/A | -80.00 | -127.20 | 220.80 | N/A |
| EPS Basic Continuous Ops | N/A | -79.90 | -127.23 | 220.84 | N/A |
| EPS Diluted Total Ops | N/A | -80.00 | -127.20 | 220.80 | N/A |
| EPS Diluted Continuous Ops | N/A | -79.90 | -127.23 | 220.84 | N/A |
| EBITDA(a) | $N/A | $-9,756 | $-7,490 | $10,697 | $N/A |